Skip Ribbon Commands
Skip to main content
Skip over global navigation links
U.S. Department of Health and Human Services
  • Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19

    FDA issued an emergency use authorization (EUA) for Paxlovid for the treatment of mild-to-moderate coronavirus disease in adults & pediatric patients (12 yrs of age & older weighing at least 40 kg or about 88 lbs) ​with positive results of direct SARS-CoV-2 testing, & who are at high risk for progression to severe COVID-19, including hospitalization or death.


    older patient getting treatment from her healthcare provider  


​PHE Newsroom

Submit an Inquiry


Watch, Listen, Subscribe

Twitter  LinkedIn  Facebook  Instagram

Watch us on YouTube  Follow us on Flickr  Subcribe to our RSS  Subscribe to our email list

  • This page last reviewed: January 05, 2022